In agreement, Casagrande and colleagues demonstrated that Timp3-overexpression in myeloid cells protected mice from streptozotocin-induced diabetic nephropathy at the same extent as ablation of ADAM17 in podocytes [100]. The gene discussed is ADAM17; the disease is diabetic kidney disease.